Title:
TRIAZOLE GLYCOLATE OXIDASE INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2020/010309
Kind Code:
A9
Abstract:
The present invention provides triazole carboxylic acids and related compounds, as well as pharmaceutically acceptable salts thereof, which are useful as glycolate oxidase inhibitors. Pharmaceutical compositions and methods for treating primary hyperoxaluria, type I (PH) and kidney stones are also described.
More Like This:
| JP2022066345 | STABLE ANTI-IFNAR1 FORMULATION |
| JP2011509289 | New acylcyanopyrrolidine derivative |
Inventors:
MAAG HANS (DE)
FERNANDES MIGUEL XAVIER (ES)
ZAMBONI ROBERT (CA)
AKBARIROMANI ELHAM (CA)
BEAULIEU MARC-ANDRE (CA)
LEBLANC YVES (CA)
THAKUR PALLAVI (CA)
FERNANDES MIGUEL XAVIER (ES)
ZAMBONI ROBERT (CA)
AKBARIROMANI ELHAM (CA)
BEAULIEU MARC-ANDRE (CA)
LEBLANC YVES (CA)
THAKUR PALLAVI (CA)
Application Number:
PCT/US2019/040690
Publication Date:
January 30, 2020
Filing Date:
July 05, 2019
Export Citation:
Assignee:
ORFAN BIOTECH INC (US)
International Classes:
A61P13/12; C07D249/04; C07D401/12; C07D403/12; C07D405/12; C07D409/12; C07D413/12; C07D417/12
Attorney, Agent or Firm:
KEZER, William B. et al. (US)
Download PDF:
Previous Patent: MULTI-SPECIFIC WNT SURROGATE MOLECULES AND USES THEREOF
Next Patent: SEALED NEUROVASCULAR EXTENDABLE CATHETER
Next Patent: SEALED NEUROVASCULAR EXTENDABLE CATHETER